In this episode, Dr. Gordon sits down with Dr. Pierre Kory to explore the challenging landscape of medical innovation and resistance to new ideas. Their conversation delves into the historical pattern of how revolutionary medical concepts face opposition from established orthodoxy and discusses Dr. Kory’s personal experience.

The discussion illuminates the complex political dynamics within the medical community and offers practical insights into long-term COVID treatments. Dr. Gordon and Dr. Kory examine various interventions that have stood the test of time, reflecting on how their initial cautious approach has evolved into greater confidence in these therapeutic strategies. 

Episode Highlights:

• Dr. Kory's journey from frontline clinician to Long COVID pioneer
• The political landscape of repurposed drugs
• Ivermectin's early results and clinical impact and how Dr. Kory put it on the map
• First-line therapies for spike protein symptoms
• Understanding MCAS in Long COVID Therapies
• Anticoagulation strategies for Long COVID management

Listen in to learn more :

(01:30) Navigating Medical Politics for COVID Treatments 
(08:56) Tackling Medical Disinformation in Science
(23:28) Optimizing Long Haul COVID Treatments 

About Pierre Kory, MD, MPA, CTP

Dr. Pierre Kory, former Chief of Critical Care Service at the University of Wisconsin, is a pioneering figure in critical care medicine. He revolutionized the field by helping establish ultrasound diagnostics as a standard practice in critical care, leading over 100 training courses nationally and internationally. He was also at the forefront of therapeutic hypothermia treatment for post-cardiac arrest patients. He established the first regular treatment program in New York City and was an expert panel member for the city's Project Hypothermia, creating cooling protocols across 44 regional hospitals.

A renowned educator and researcher, Dr. Kory has made significant contributions to critical care medicine through his groundbreaking work with Dr. Paul Marik on treating septic shock using high-dose intravenous ascorbic acid. His research was pivotal in identifying the crucial relationship between therapy initiation timing and survival rates in septic shock patients. During the COVID-19 pandemic, Dr. Kory emerged as a frontline leader, directing ICUs in multiple hotspots, including New York City, Greenville, South Carolina, and Milwaukee, Wisconsin. His expertise in COVID-19 treatment is reflected in his co-authorship of five influential papers on the disease, including pioneering work on early COVID-19 respiratory diagnosis.

FLCCC Alliance:  https://covid19criticalcare.com/

💬 Text us your feedback and future show ideas! (Please note we can't respond to texts - email questions to [email protected])

Interested in Becoming A Patient?

Find out if working with Gordon Medical is right for you. Set up a complimentary discovery call with our new patient coordinator at www.gordonmedical.com.

** This information is not to be taken as medical advice. Always consult your practitioner before making any changes to your treatment.